BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: da Cunha Jaeger M, Ghisleni EC, Cardoso PS, Siniglaglia M, Falcon T, Brunetto AT, Brunetto AL, de Farias CB, Taylor MD, Nör C, Ramaswamy V, Roesler R. HDAC and MAPK/ERK Inhibitors Cooperate To Reduce Viability and Stemness in Medulloblastoma. J Mol Neurosci 2020;70:981-92. [PMID: 32056089 DOI: 10.1007/s12031-020-01505-y] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 5.5] [Reference Citation Analysis]
Number Citing Articles
1 Perla A, Fratini L, Cardoso PS, Nör C, Brunetto AT, Brunetto AL, de Farias CB, Jaeger M, Roesler R. Histone Deacetylase Inhibitors in Pediatric Brain Cancers: Biological Activities and Therapeutic Potential. Front Cell Dev Biol 2020;8:546. [PMID: 32754588 DOI: 10.3389/fcell.2020.00546] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
2 Schönholzer MT, Migliavacca J, Alvarez E, Santhana Kumar K, Neve A, Gries A, Ma M, Grotzer MA, Baumgartner M. Real-time sensing of MAPK signaling in medulloblastoma cells reveals cellular evasion mechanism counteracting dasatinib blockade of ERK activation during invasion. Neoplasia 2020;22:470-83. [PMID: 32818841 DOI: 10.1016/j.neo.2020.07.006] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 2.5] [Reference Citation Analysis]
3 Guo Q, Shi D, Lin L, Li H, Wei Y, Li B, Wu D. De-Ubiquitinating Enzymes USP21 Regulate MAPK1 Expression by Binding to Transcription Factor GATA3 to Regulate Tumor Growth and Cell Stemness of Gastric Cancer. Front Cell Dev Biol 2021;9:641981. [PMID: 33791299 DOI: 10.3389/fcell.2021.641981] [Reference Citation Analysis]
4 Guo J, Guo M, Zheng J. Inhibition of Bone Morphogenetic Protein 2 Suppresses the Stemness Maintenance of Cancer Stem Cells in Hepatocellular Carcinoma via the MAPK/ERK Pathway. Cancer Manag Res 2021;13:773-85. [PMID: 33536785 DOI: 10.2147/CMAR.S281969] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Shofuda T, Kanemura Y. HDACs and MYC in medulloblastoma: how do HDAC inhibitors control MYC-amplified tumors? Neuro Oncol. 2021;23:173-174. [PMID: 33394043 DOI: 10.1093/neuonc/noaa292] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Paul MR, Zage PE. Overview and recent advances in the targeting of medulloblastoma cancer stem cells. Expert Rev Anticancer Ther 2021;21:957-74. [PMID: 34047251 DOI: 10.1080/14737140.2021.1932472] [Reference Citation Analysis]
7 Shrestha S, Morcavallo A, Gorrini C, Chesler L. Biological Role of MYCN in Medulloblastoma: Novel Therapeutic Opportunities and Challenges Ahead. Front Oncol 2021;11:694320. [PMID: 34195095 DOI: 10.3389/fonc.2021.694320] [Reference Citation Analysis]
8 Abballe L, Miele E. Epigenetic modulators for brain cancer stem cells: Implications for anticancer treatment. World J Stem Cells 2021; 13(7): 670-684 [PMID: 34367473 DOI: 10.4252/wjsc.v13.i7.670] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
9 He Q, Liu H, Deng S, Chen X, Li D, Jiang X, Zeng W, Lu W. The Golgi Apparatus May Be a Potential Therapeutic Target for Apoptosis-Related Neurological Diseases. Front Cell Dev Biol 2020;8:830. [PMID: 33015040 DOI: 10.3389/fcell.2020.00830] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
10 Kim E, Ahuja A, Kim MY, Cho JY. DNA or Protein Methylation-Dependent Regulation of Activator Protein-1 Function. Cells 2021;10:461. [PMID: 33670008 DOI: 10.3390/cells10020461] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
11 Strejczek A, Woszczyk D, Urbaniak H, Różańska M, Robak M, Matuszewska Z, Barciszewska AM. Epigenetic-Based Therapy-A Prospective Chance for Medulloblastoma Patients' Recovery. Int J Mol Sci 2021;22:4925. [PMID: 34066495 DOI: 10.3390/ijms22094925] [Reference Citation Analysis]
12 Souza BK, Freire NH, Jaeger M, de Farias CB, Brunetto AL, Brunetto AT, Roesler R. EHMT2/G9a as an Epigenetic Target in Pediatric and Adult Brain Tumors. Int J Mol Sci 2021;22:11292. [PMID: 34681949 DOI: 10.3390/ijms222011292] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]